Short Interest Summary: Is Buying Colgate Palmolive Company (NYSE:CL), Having Lower Short Interest a Winning Strategy?

November 29, 2016 - By Ruchi Gupta   ·   0 Comments

Short Interest Summary: Is Buying Colgate Palmolive Company (NYSE:CL), Having Lower Short Interest a Winning Strategy?

The stock of Colgate Palmolive Company (NYSE:CL) registered a decrease of 1.66% in short interest. CL’s total short interest was 8.95M shares in November as published by FINRA. Its down 1.66% from 9.10M shares, reported previously. With 3.02M shares average volume, it will take short sellers 3 days to cover their CL’s short positions. The short interest to Colgate Palmolive Company’s float is 1.04%. About 1.35 million shares traded hands. Colgate-Palmolive Company (NYSE:CL) has declined 3.67% since April 26, 2016 and is downtrending. It has underperformed by 8.93% the S&P500.

Colgate-Palmolive Company is a consumer products company, whose products are marketed in over 200 countries and territories throughout the world. The company has a market cap of $59.18 billion. The Company’s divisions include Oral, Personal and Home Care, and Pet Nutrition. It has a 43.65 P/E ratio. The Oral, Personal and Home Care product segment is operated through over five geographic divisions, which include North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia.

Insitutional Activity: The institutional sentiment increased to 0.89 in 2016 Q2. Its up 0.02, from 0.87 in 2016Q1. The ratio increased, as 47 funds sold all Colgate-Palmolive Company shares owned while 440 reduced positions. 53 funds bought stakes while 371 increased positions. They now own 618.55 million shares or 5.94% less from 657.64 million shares in 2016Q1.
Kistler accumulated 0.07% or 1,864 shares. Jane Street Gru Ltd Liability Corporation accumulated 0.04% or 111,739 shares. Tctc Llc accumulated 0.13% or 26,560 shares. Moreover, Eads And Heald Investment Counsel has 1.44% invested in Colgate-Palmolive Company (NYSE:CL) for 28,618 shares. Security National Tru Com accumulated 1.4% or 52,049 shares. Kornitzer Capital Inc Ks has invested 0.27% of its portfolio in Colgate-Palmolive Company (NYSE:CL). Motco accumulated 0.07% or 8,507 shares. Huntington Comml Bank has invested 0.55% of its portfolio in Colgate-Palmolive Company (NYSE:CL). Eagleclaw Capital Managment Ltd Liability Com holds 33,664 shares or 1.64% of its portfolio. Northstar Grp Inc Inc holds 0.27% or 4,994 shares in its portfolio. Moreover, Vision has 0.25% invested in Colgate-Palmolive Company (NYSE:CL) for 8,220 shares. Ftb Advsrs has 0.13% invested in the company for 12,859 shares. Eaton Vance, a Massachusetts-based fund reported 1.62 million shares. Piedmont Invest Advsrs Limited Liability Corp accumulated 197,226 shares or 0% of the stock. New England Rech And Management accumulated 0.46% or 7,300 shares.

Insider Transactions: Since June 15, 2016, the stock had 0 buys, and 12 selling transactions for $11.28 million net activity. 8,000 shares were sold by KOGAN RICHARD J, worth $597,254 on Wednesday, August 10. $264,649 worth of shares were sold by Verduin Patricia on Wednesday, June 15. 78,849 Colgate-Palmolive Company (NYSE:CL) shares with value of $5.89M were sold by Wallace Noel R.. $653,927 worth of Colgate-Palmolive Company (NYSE:CL) shares were sold by SADOVE STEPHEN I. Shares for $1.05 million were sold by HUSTON JOHN J on Wednesday, August 10. MOISON FRANCK J also sold $1.13M worth of Colgate-Palmolive Company (NYSE:CL) on Thursday, August 11. $342,954 worth of Colgate-Palmolive Company (NYSE:CL) shares were sold by HANCOCK ELLEN M.

Colgate-Palmolive Company (NYSE:CL) Ratings Coverage

Out of 17 analysts covering Colgate-Palmolive (NYSE:CL), 3 rate it a “Buy”, 0 “Sell”, while 14 “Hold”. This means 18% are positive. Colgate-Palmolive has been the topic of 30 analyst reports since July 21, 2015 according to StockzIntelligence Inc. As per Friday, February 26, the company rating was downgraded by Sterne Agee CRT. The stock has “Neutral” rating given by UBS on Friday, July 29. The stock of Colgate-Palmolive Company (NYSE:CL) earned “Buy” rating by Citigroup on Thursday, April 14. Atlantic Securities initiated Colgate-Palmolive Company (NYSE:CL) on Wednesday, January 6 with “Overweight” rating. The firm earned “Neutral” rating on Friday, October 28 by UBS. The stock of Colgate-Palmolive Company (NYSE:CL) earned “Buy” rating by Bank of America on Monday, September 12. Wells Fargo reinitiated Colgate-Palmolive Company (NYSE:CL) on Tuesday, November 15 with “Market Perform” rating. The rating was downgraded by RBC Capital Markets on Monday, January 4 to “Sector Perform”. As per Friday, July 31, the company rating was maintained by UBS. S&P Research maintained it with “Hold” rating and $69 target price in Monday, November 2 report.

CL Company Profile

Colgate-Palmolive Company (Colgate), incorporated on July 25, 1923, is a consumer products company, whose products are marketed in over 200 countries and territories throughout the world. The Firm operates in two product divisions: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through over five geographic divisions, which include North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia. The Company’s oral care products include Colgate Total; Colgate Sensitive Pro-Relief; Colgate Max Fresh; Colgate Maximum Cavity Protection with Sugar Acid Neutralizer; Colgate Optic White and Colgate Luminous White toothpastes, and Colgate Optic White, Colgate Total and Colgate Plax mouthwashes. Colgate’s Oral Care business also includes pharmaceutical products for dentists and other oral health professionals. The Firm sells its personal care products under the Palmolive, Protex and Softsoap brands. The Company, through its Hill’s Pet Nutrition segment (Hill’s), makes pet nutrition products for dogs and cats with products marketed in over 80 countries across the world.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Ruchi Gupta

Tags: ,


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>